ArticleCancer management and research2019

Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection.

Yumei Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.